Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy

Luiz Carlos Porcello Marrone; Bianca Fontana Marrone; Tharick Ali Pascoal; Lucas Porcello Schilling; Ricardo Bernardi Soder; Sheila Schuch Ferreira; Giovani Gadonski; Jaderson Costa da Costa

doi:10.1155/2013/306983

Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy

Case Rep Oncol Med. 2013:2013:306983. doi: 10.1155/2013/306983. Epub 2013 Feb 27.

Authors

Luiz Carlos Porcello Marrone¹, Bianca Fontana Marrone, Tharick Ali Pascoal, Lucas Porcello Schilling, Ricardo Bernardi Soder, Sheila Schuch Ferreira, Giovani Gadonski, Jaderson Costa da Costa

Affiliation

¹ Hospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, Brazil.

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.